ARTICLE | Distillery Therapeutics
Neurology
June 7, 2017 3:55 PM UTC
In vitro and mouse studies suggest inhibiting DNM1L could help treat AD. In primary rat hippocampal neurons exposed to β-amyloid oligomers, a DNM1L inhibitor tool compound decreased mitochondrial frag...
BCIQ Target Profiles